Partial protection against 2009 pandemic influenza A (H1N1) of seasonal influenza vaccination and related regional factors: Updated systematic review and meta-analyses

References

• Sekkides O. Pandemic influenza—a timeline. Lancet Infect Dis 2010; 10:663; PMID:20931693
   PubMedGoogle Scholar
• Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, Balish A, Sessions WM, Xu X, Skepner E, Deyde V, et al. Antigenic and genetic characteristics of swine-origin 2009 A (H1N1) influenza viruses circulating in humans. Science 2009; 325:197-201PMID:19465683
   PubMedGoogle Scholar
• Malik Peiris J, Poon LL, Guan Y. Emergence of a novel swine-origin influenza A virus (S-OIV) H1N1 virus in humans. J Clin Virol 2009; 45(3):169-73; PMID:19540800; http://dx.doi.org/10.1016/j.jcv.2009.06.006
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global alert and response (GAR). [cited February 2014]; Available from: http://www.who.int/csr/don/2010_05_14/en/
   Google Scholar
• Echevarría-Zuno S, Mejía-Aranguré JM, Mar-Obeso AJ, Grajales-Muñiz C, Robles-Pérez E, González-León M, Ortega-Alvarez MC, Gonzalez-Bonilla C, Rascón-Pacheco RA, Borja-Aburto VH. Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis. The Lancet 2010; 374(9707):2072-9; PMID:19913290; http://dx.doi.org/10.1016/S0140-6736(09)61638-X
   PubMedGoogle Scholar
• Garcia-Garcia L, Valdespino-Gómez JL, Lazcano-Ponce E, Jimenez-Corona A, Higuera-Iglesias A, Cruz-Hervert P, Cano-Arellano B, Garcia-Anaya A, Ferreira-Guerrero E, Baez-Saldaña R, et al. Partial protection of seasonal trivalent inactivated vaccine against novel pandemic influenza A/H1N1 2009: case-control study in Mexico City. BMJ (Clinical research ed) 2009; 339:b3928; PMID:19808768
   PubMedGoogle Scholar
• Johns MC, Eick AA, Blazes DL, Lee SE, Perdue CL, Lipnick R, et al. Seasonal influenza vaccine and protection against pandemic (H1N1) 2009-associated illness among US military personnel. PloS one. 2010; 5(5):e10722; PMID:20502705; http://dx.doi.org/10.1371/journal.pone.0010722
   PubMedGoogle Scholar
• Orellano PW, Reynoso JI, Carlino O, Uez O. Protection of trivalent inactivated influenza vaccine against hospitalizations among pandemic influenza A (H1N1) cases in Argentina. Vaccine. 2010 Jul 19; 28(32):5288-91; PMID:20541580; http://dx.doi.org/10.1016/j.vaccine.2010.05.051
   PubMed Web of Science ®Google Scholar
• Hardelid P, Fleming DM, McMenamin J, Andrews N, Robertson C, Sebastian Pillai P, Ellis J, Carman W, Wreghitt T, Watson JM, et al. Effectiveness of pandemic and seasonal influenza vaccine in preventing pandemic influenza A (H1N1) 2009 infection in England and Scotland 2009–2010. Euro surveill 2011; 16(2); PMID:21251487
   PubMedGoogle Scholar
• Valenciano M, Kissling E, Cohen JM, Oroszi B, Barret AS, Rizzo C, Nunes B, Pitigoi D, Larrauri Cámara A, Mosnier A, et al. Estimates of pandemic influenza vaccine effectiveness in Europe, 2009–2010: Results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) multicentre case-control study. PLoS Med. 2011; 8(1):e1000388; PMID:21379316
   PubMed Web of Science ®Google Scholar
• Cowling BJ, Ng S, Ma ESK, Fang VJ, So HC, Wai W, Cheng CK, Wong JY, Chan KH, Ip DK, et al. Protective efficacy against pandemic influenza of seasonal influenza vaccination in children in Hong Kong: A randomized controlled trial. Clin Infect Dis 2012; 55(5):695-702; PMID:22670050; http://dx.doi.org/10.1093/cid/cis518
   PubMed Web of Science ®Google Scholar
• Richmond P, et al. A Study of the Efficacy, Safety and Tolerability Profile of CSL Limited's Influenza Virus Vaccine (CSL's IVV) Administered Intramuscularly in Healthy Adults) ClinicalTrials.gov Identifier: NCT00562484. Available from: http://www.clinicaltrials.gov/ct2/show/study/NCT00562484?term=NCT00562484&rank=1
   Google Scholar
• Kelly HA, Grant KA, Fielding JE, Carville KS, Looker CO, Tran T, Jacoby P. Pandemic influenza H1N1 2009 infection in Victoria, Australia: No evidence for harm or benefit following receipt of seasonal influenza vaccine in 2009. Vaccine 2011 ; 29(37):6419-26; PMID:21473950; http://dx.doi.org/10.1016/j.vaccine.2011.03.055
   PubMedGoogle Scholar
• Van Buynder PG, Dhaliwal JK, Van Buynder JL, Couturier C, Minville-Leblanc M, Garceau R, et al. Protective effect of single-dose adjuvanted pandemic influenza vaccine in children. Influenza Other Respi Viruses. 2010; 4(4):171-8; PMID:20629771; http://dx.doi.org/10.1111/j.1750-2659.2010.00146.x
   PubMedGoogle Scholar
• Skowronski DM, De Serres G, Crowcroft NS, Janjua NZ, Boulianne N, Hottes TS, Rosella LC, Dickinson JA, Gilca R, Sethi P, et al. Association between the 2008–2009 seasonal influenza vaccine and pandemic H1N1 illness during Spring to Summer 2009: Four observational studies from Canada. PLoS Med 2010; 7(4):e1000258; PMID:20386731
   PubMed Web of Science ®Google Scholar
• Jefferies S, Earl D, Berry N, Blackmore T, Rooker S, Raymond N, Pritchard A, Weatherall M, Beasley R, Perrin K. Effectiveness of the 2009 seasonal influenza vaccine against pandemic influenza A (H1N1) 2009 in healthcare workers in New Zealand, June to August 2009. Euro Surveill. 2011; 16(2); PMID:21251486
   PubMedGoogle Scholar
• Kelly H, Barry S, Laurie K, Mercer G. Seasonal influenza vaccination and the risk of infection with pandemic influenza: a possible illustration of non-specific temporary immunity following infection. Challenge 2010; 16:17.
   Google Scholar
• Cowling BJ, Ng S, Ma ESK, Cheng CKY, Wai W, Fang VJ, Chan KH, Ip DK, Chiu SS, Peiris JS, et al. Protective efficacy of seasonal influenza vaccination against seasonal and pandemic influenza virus infection during 2009 in Hong Kong. Clin Infect Dis 2010; 51(12):1370-9 PMID:21067351
   PubMedGoogle Scholar
• Klick B, Durrani S, Chan KH, Ip DKM, Chou ESK, Kwok HKH, Ng S, Chiu SS, Peiris JS, Leung GM, et al. Live attenuated seasonal and pandemic influenza vaccine in school-aged children: A randomized controlled trial. Vaccine. 2013; 31(15):1937-43; PMID:23434387; http://dx.doi.org/10.1016/j.vaccine.2013.02.017
   PubMedGoogle Scholar
• Yin JK, Chow MYK, Khandaker G, King C, Richmond P, Heron L, Booy R. Impacts on influenza A (H1N1) pdm09 infection from cross-protection of seasonal trivalent influenza vaccines and A (H1N1) pdm09 vaccines: Systematic review and meta-analyses. Vaccine 2012; 30(21):3209-22; PMID:22387221; http://dx.doi.org/10.1016/j.vaccine.2012.02.048
   PubMedGoogle Scholar
• Fiore AE, Shay DK, Broder K, Iskander JK, Uyeki TM, Mootrey G, et al. Prevention and control of seasonal influenza with vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. Morbidity and Mortality Weekly Report 2009; 58(RR8):1–51
   Google Scholar
• Carcione D, Giele C, Goggin LS, Kwan KS, Smith DW, Dowse GK, Mak DB, Effler P. Association between 2009 seasonal influenza vaccine and influenza-like illness during the 2009 pandemic: preliminary results of a large household transmission study in Western Australia. Euro Surveill 2010; 15(28); PMID:20650055
   Google Scholar
• Yin JK, Wang H, Skinner SR, Salkeld G, Booy R. Assessing seasonal vaccine-related cross-protection from 2009 pandemic H1N1 influenza through teacher absenteeism. Aust N Z J Public Health 2011; 35(4):393-4; PMID:21806738; http://dx.doi.org/10.1111/j.1753-6405.2011.00748.x
   PubMedGoogle Scholar
• Janjua NZ, Skowronski DM, Hottes TS, Osei W, Adams E, Petric M, Sabaiduc S, Chan T, Mak A, Lem M, et al. Seasonal influenza vaccine and increased risk of pandemic A/H1N1-related illness: first detection of the association in British Columbia, Canada. Clin Infect Dis 2010; 51(9):1017-27; PMID:20887210; http://dx.doi.org/10.1086/656586
   PubMedGoogle Scholar
• Larrauri A, Savulescu C, Jimenez-Jorge S, Perez-Brena P, Pozo F, Casas I, Ledesma J, de Mateo S; Spanish Influenza Surveillance System (SISS). Influenza pandemic (H1N1) 2009 activity during summer 2009. Effectiveness of the 2008 to 2009 trivalent vaccine against pandemic influenza in Spain. Gaceta Sanitaria 2011; 25(1):23-8; PMID:21334788
   PubMedGoogle Scholar
• Danielle Luliano AA, Reed C, Gun A, Desai M, Dee DL, Kutty P, Gould LH, Sotir M, Grant G, Lynch M, et al. Notes from the field: outbreak of 2009 pandemic influenza A (H1N1) virus at a large public University in Delaware, April to May 2009. Clin Infect Dis 2009; 49(12):1811-20; PMID:19911964; http://dx.doi.org/10.1086/649555
   PubMedGoogle Scholar
• Mahmud SM, Van Caeseele P, Hammond G, Kurbis C, Hilderman T, Elliott L. No association between 2008–09 influenza Vaccine and Influenza A (H1N1) pdm09 virus infection, Manitoba, Canada, 2009. Emer Infecti Dis 2012; 18(5):801; PMID:22516189; http://dx.doi.org/10.3201/eid1805.111596
   PubMedGoogle Scholar
• Nelson CA, France EK, Shetterly SM, Glanz JM. Seasonal influenza vaccination status among children with laboratory evidence of pandemic H1N1 infection. Pediat Infect Dis J 2011; 30(7):562-5; PMID:21248657; http://dx.doi.org/10.1097/INF.0b013e31820bb482
   PubMedGoogle Scholar
• Pebody R, Andrews N, Waight P, Malkani R, McCartney C, Ellis J, Miller E. No effect of 2008/09 seasonal influenza vaccination on the risk of pandemic H1N1 2009 influenza infection in England. Vaccine 2011; 29(14):2613-8; PMID:21292008; http://dx.doi.org/10.1016/j.vaccine.2011.01.046
   PubMed Web of Science ®Google Scholar
• Puig-Barbera J, Arnedo-Pena A, Pardo-Serrano F, Tirado-Balaguer MD, Perez-Vilar S, Silvestre-Silvestre E, Calvo-Mas C, Safont-Adsuara L, Ruiz-García M; Surveillance and Vaccine Evaluation Group during the autumn 2009 H1N1 pandemic wave in Castellón, Spain. Effectiveness of seasonal 2008–2009, 2009–2010, and pandemic vaccines, to prevent influenza hospitalizations during the autumn 2009 influenza pandemic wave in Castellon, Spain. A test-negative, hospital-based, case-control study. Vaccine 2010; 28(47):7460-7PMID:20875486
   PubMed Web of Science ®Google Scholar
• Tsuchihashi Y, Sunagawa T, Yahata Y, Takahashi H, Toyokawa T, Odaira F, Ohyama T, Taniguchi K, Okabe N. Association between seasonal influenza vaccination in 2008–2009 and pandemic influenza A (H1N1) 2009 infection among school students from Kobe, Japan, April to June 2009. Clin Infect Dis 2012; 54(3):381-3; PMID:22100572
   PubMedGoogle Scholar
• Xiang Z, Yi-lin H, Hai-yun Y. A retrospective evaluation of protective effect of seasonal influenza vaccine and influenza A (H1N1) vaccine. Chinese J Dis Cont Prevent ISTIC 2012; 16(5):452–54
   Google Scholar
• Gargiullo P, Shay D, Katz J, Bramley A, Nowell M, Michalove J, Kamimoto L, Singleton JA, Lu PJ, Balluz L, et al. Effectiveness of 2008–09 trivalent influenza vaccine against 2009 pandemic influenza A (H1N1) – United States, May–June 2009. Morbidity and Mortality Weekly Report 2009; 58(44):1241–5
   Google Scholar
• Lessler J, Reich NG, Cummings DA. Outbreak of 2009 pandemic influenza A (H1N1) at a New York City school. N Engl J Med. 2009; 361(27):2628-36; PMID:20042754; http://dx.doi.org/10.1056/NEJMoa0906089
   PubMedGoogle Scholar
• Pelat C, Falchi A, Carrat F, Mosnier A, Bonmarin I, Turbelin C, Vaux S, van der Werf S, Cohen JM, Lina B, et al. Field effectiveness of pandemic and 2009–2010 seasonal vaccines against 2009–2010 A (H1N1) influenza: estimations from surveillance data in France. PloS One. 2011; 6(5):e19621; PMID:21573005
   PubMed Web of Science ®Google Scholar
• Corti D, Suguitan Jr AL, Pinna D, Silacci C, Fernandez-Rodriguez BM, Vanzetta F, et al. Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine. J Clin Invest 2010; 120(5):1663; PMID:20389023; http://dx.doi.org/10.1172/JCI41902
   PubMed Web of Science ®Google Scholar
• Bethell D, Saunders D, Jongkaewwattana A, Kramyu J, Thitithayanont A, Wiboon-ut S, Yongvanitchit K, Limsalakpetch A, Kum-Arb U, Uthaimongkol N, et al. Evaluation of in vitro cross-reactivity to avian H5N1 and pandemic H1N1 2009 influenza following prime boost regimens of seasonal influenza vaccination in healthy human subjects: a randomised trial. PloS One 2013; 8(3):e59674.
   PubMed Web of Science ®Google Scholar
• De Groot AS, Ardito M, McClaine EM, Moise L, Martin WD. Immunoinformatic comparison of T-cell epitopes contained in novel swine-origin influenza A (H1N1) virus with epitopes in 2008–2009 conventional influenza vaccine. Vaccine 2009; 27(42):5740-7; PMID:19660593; http://dx.doi.org/10.1016/j.vaccine.2009.07.040
   PubMed Web of Science ®Google Scholar
• Echevarría-Zuno S, Mejía-Aranguré JM, Grajales-Muñiz C, Gonzalez-Bonilla C, Borja-Aburto VH. Seasonal vaccine effectiveness against pandemic A/H1N1 - Authors' reply. The Lancet. 2010; 375(9717):802-3; http://dx.doi.org/10.1016/S0140-6736(10)60339-X
   Web of Science ®Google Scholar
• Tumpey TM, García-Sastre A, Taubenberger JK, Palese P, Swayne DE, Basler CF. Pathogenicity and immunogenicity of influenza viruses with genes from the 1918 pandemic virus. Proc Natl Acad Sci U S A. 2004; 101(9):3166-71; PMID:14963236
   PubMedGoogle Scholar
• Mogabgab WJ, Leiderman E. Immunogenicity of 1967 polyvalent and 1968 Hong Kong influenza vaccines. JAMA. 1970; 211(10):1672-6; PMID:4984268
   PubMedGoogle Scholar
• Crowcroft NS, Rosella LC. The potential effect of temporary immunity as a result of bias associated with healthy users and social determinants on observations of influenza vaccine effectiveness; could unmeasured confounding explain observed links between seasonal influenza vaccine and pandemic H1N1 infection? BMC Public Health 2012; 12:458; PMID:22716096; http://dx.doi.org/10.1186/1471-2458-12-458
   PubMedGoogle Scholar
• Ekiert DC, Bhabha G, Elsliger M-A, Friesen RH, Jongeneelen M, Throsby M, Goudsmit J, Wilson IA. Antibody recognition of a highly conserved influenza virus epitope. Science 2009; 324(5924):246-51; PMID:19251591
   PubMed Web of Science ®Google Scholar
• Pica N, Hai R, Krammer F, Wang TT, Maamary J, Eggink D, Tan GS, Krause JC, Moran T, Stein CR, et al. Haemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses. Proc Natl Acad Sci 2012; 109(7):2573-8; PMID:22308500; http://dx.doi.org/10.1073/pnas.1200039109
   PubMed Web of Science ®Google Scholar
• Gilbert PB, Qin L, Self SG. Evaluating a surrogate endpoint at three levels, with application to vaccine development. Stat Med 2008; 27(23):4758-78; PMID:17979212; http://dx.doi.org/10.1002/sim.3122
   PubMedGoogle Scholar
• Orenstein EW, De Serres G, Haber MJ, Shay DK, Bridges CB, Gargiullo P, Orenstein WA. Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. Int J Epidemiol 2007; 36(3):623-31; PMID:17403908; http://dx.doi.org/10.1093/ije/dym021
   PubMed Web of Science ®Google Scholar
• Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, Sun H, Liu F, Dong L, DeVos JR, Gargiullo PM, et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009; 361(20):1945-52; PMID:19745214
   PubMed Web of Science ®Google Scholar
• Booy R, Khandaker G, Heron LG, Yin J, Doyle B, Tudo KK, Hueston L, Gilbert GL, Macintyre CR, Dwyer DE. Cross-reacting antibodies against the pandemic (H1N1) 2009 influenza virus in older Australians. Med J Aust 2011; 194(1):19; PMID:21449863
   PubMed Web of Science ®Google Scholar
• Ikonen N, Strengell M, Kinnunen L, Osterlund P, Pirhonen J, Broman M, et al. High frequency of cross-reacting antibodies against 2009 pandemic influenza A (H1N1) virus among the elderly in Finland. Euro Surveill 2010; 15(5):19478; PMID:20144443
   PubMedGoogle Scholar
• Katz J, Hancock K, Veguilla V, Zhong W, Lu XH, Sun H, Butler E, Dong L ,Liu F, Li ZN. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine (Reprinted from MMWR, vol 58, 2009, pp 521–524, 2009). Jama-Journal of the American Medical Association 2009; 302(3):249–50
   Google Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Annal Int Med 2009; 151(4):264-9; PMID:19622511; http://dx.doi.org/10.7326/0003-4819-151-4-200908180-00135
   PubMed Web of Science ®Google Scholar
• Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ, McQuay HJ. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Cont Clin Ttrial 1996; 17(1):1–12
   Google Scholar
• Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials. BMC Med 2010; 8(1):18
   PubMed Web of Science ®Google Scholar
• Higgins J, Green S. Chapter 8: Assessing risk of bias in included studies. Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0 (updated March 2011). [cited 11 February 2013]; Available from: www.cochranehandbook.org.
   Google Scholar
• Wells G, Shea B, O’Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Hospital Research Institute URL: http://www.ohrica/programs/clinical_epidemiology/oxford_htm Accessed on. 2012; 2.
   Google Scholar
• Bailey K R. Inter-study differences: how should they influence the interpretation and analysis of results? Stat Med 1987; 6(3): 351-358.
   PubMed Web of Science ®Google Scholar
• Higgins J, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21(11):1539-58; PMID:12111919; http://dx.doi.org/10.1002/sim.1186
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327(7414):557; PMID:12958120
   PubMed Web of Science ®Google Scholar
• Begg CB, Berlin JA. Publication bias and dissemination of clinical research. J Natl Cancer Inst 1989; 81(2):107-15; PMID:2642556; http://dx.doi.org/10.1093/jnci/81.2.107
   PubMed Web of Science ®Google Scholar